ARTICLE AD BOX
Scientists at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two brain receptors that help regulate the breakdown of amyloid beta, the protein that builds up in Alzheimer's disease. Their findings suggest it may be possible to develop future medications that are both safer and more affordable than today's antibody based treatments.
Alzheimer's disease is the leading cause of dementia and is marked by sticky clum...

4 hours ago
5








English (US) ·